Lung Cancer Clinical Trials in San Antonio

Showing 521-540 of 570 trials

Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer

NCT00066742

This phase II trial is studying how well giving tirapazamine together with cisplatin, etoposide, and radiation therapy works in treating patients with limited-stage small cell lung cancer. Drugs used in chemotherapy, such as cisplatin and etoposide, work in different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Tirapazamine may make the tumor cells more sensitive to chemotherapy and radiation therapy. Combining chemotherapy and radiation therapy with tirapazamine may kill more tumor cells.

Limited Stage Small Cell Lung Cancer

National Cancer Institute (NCI)72 participantsStarted Sep 2003

San Antonio, Texas, United States

COMPLETEDPhase 2< 1 mile

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

NCT00600821

To determine if the addition of AG-013736 to chemotherapy is beneficial in patients with advanced lung cancer who have not been previously treated.

Non-Small-Cell Lung CarcinomaAdenocarcinoma

Pfizer118 participantsStarted Apr 2008

Baton Rouge, Louisiana, United States • Pittsfield, Massachusetts, United States • Columbus, Mississippi, United States +41 more locations

Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

Lung Cancer Trials in Other Cities

Safety of Adding IMO-2055 to Erlotinib + Bevacizumab in 2nd Line Treatment for Patients With NSCLC

Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer

An Open-label Study of GSK1120212 Compared With Docetaxel in Stage IV KRAS-mutant Non-small Cell Lung Cancer

Monotherapy Pazopanib in Subjects With Advanced Non-Small Cell Lung Cancer

Phase 2b Study of Cetuximab With Platinum-Based Chemo as First Line Treatment of Recurrent or Advanced NSCLC

Carboplatin, Paclitaxel, and Radiation Therapy With or Without Thalidomide in Patients With Stage III Non-small Cell Lung Cancer

Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer

BB-10901 in Treating Patients With Relapsed or Refractory Solid Tumors

National Lung Screening Trial (NLST) Screening

Marimastat in Treating Patients With Stage III Non-small Cell Lung Cancer

VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer

Extensive Small Cell Lung Cancer Treatment Using An Investigational Drug Plus Chemotherapy In Chemotherapy-Naive Adults

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC

Airway Epithelium Gene Expression: AEGIS IDE

Airway Epithelium Gene Expression in the Diagnosis of Lung Cancer: AEGIS CLIA

Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer

A Study of Avastin (Bevacizumab) in Combination With Carboplatin-Based Chemotherapy in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer.

Other Conditions in San Antonio